Methotrexate-induced lung damage in a patient with rheumatoid arthritis

We herein report a case of interstitial lung disease secondary to the use of methotrexate in a patient with rheumatoid arthritis. Differential diagnosis between pneumonitis caused by methotrexate in patients treated with basic methotrexate therapy and interstitial pulmonary disease associated with r...

Full description

Bibliographic Details
Main Authors: Liubov A. Ponomareva, Daria V. Gurova, Elena N. Popova, Natalia V. Chebotareva, Inna B. Bondarenko, Sergey V. Moiseev
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2021-03-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/64973/47826
Description
Summary:We herein report a case of interstitial lung disease secondary to the use of methotrexate in a patient with rheumatoid arthritis. Differential diagnosis between pneumonitis caused by methotrexate in patients treated with basic methotrexate therapy and interstitial pulmonary disease associated with rheumatoid arthritis is based on the clinical examination and instrumental data. The main condition for favorable clinical outcome in all drug-induced lung disease is drug withdrawal, what was proven in our report.
ISSN:0040-3660
2309-5342